Found 5 results
Name | Type of Offering | Accepted Date |
---|---|---|
Lapix Therapeutics Inc.
|
D | 2023-04-27 12:52:14 |
Amount To Be Raised
$14,557,480
Associated Brokers / Dealers
N/A
CIK Number
0001947620
Filed Document
0001947620-23-000001
Exclusions or Exemptions
506b
Accepted Date
2023-04-27 12:52:14
Type of Offering
D
Industry
Biotechnology
Offering Tier
N/A
Principal Place of Business
MASSACHUSETTS
Revenue or Assets
Decline to Disclose
Type of Security
Equity
|
||
Lapix Therapeutics Inc.
|
D | 2024-08-19 09:57:19 |
Amount To Be Raised
$5,499,999
Associated Brokers / Dealers
N/A
CIK Number
0001947620
Filed Document
0001947620-24-000001
Exclusions or Exemptions
506b
Accepted Date
2024-08-19 09:57:19
Type of Offering
D
Industry
Biotechnology
Offering Tier
N/A
Principal Place of Business
MASSACHUSETTS
Revenue or Assets
Decline to Disclose
Type of Security
Equity
|
||
Lapix Therapeutics Inc.
|
D | 2025-08-05 13:31:43 |
Amount To Be Raised
$5,000,000
Associated Brokers / Dealers
N/A
CIK Number
0001947620
Filed Document
0001947620-25-000003
Exclusions or Exemptions
506b
Accepted Date
2025-08-05 13:31:43
Type of Offering
D
Industry
Other Technology
Offering Tier
N/A
Principal Place of Business
MASSACHUSETTS
Revenue or Assets
Decline to Disclose
Type of Security
Other
|
||
Lapix Therapeutics Inc.
|
D | 2022-10-18 12:07:08 |
Amount To Be Raised
$1,500,000
Associated Brokers / Dealers
N/A
CIK Number
0001947620
Filed Document
0001947620-22-000002
Exclusions or Exemptions
506b
Accepted Date
2022-10-18 12:07:08
Type of Offering
D
Industry
Other Technology
Offering Tier
N/A
Principal Place of Business
MASSACHUSETTS
Revenue or Assets
Decline to Disclose
Type of Security
Other
|
||
Lapix Therapeutics Inc.
|
D/A | 2025-02-10 16:15:14 |
Amount To Be Raised
$6,000,000
Associated Brokers / Dealers
N/A
CIK Number
0001947620
Filed Document
0001947620-25-000001
Exclusions or Exemptions
506b
Accepted Date
2025-02-10 16:15:14
Type of Offering
D/A
Industry
Biotechnology
Offering Tier
N/A
Principal Place of Business
MASSACHUSETTS
Revenue or Assets
Decline to Disclose
Type of Security
Equity
|